Modular Medical (MODD) Competitors $2.06 -0.04 (-1.90%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MODD vs. NPCE, ZYXI, ELMD, LUNG, SKIN, PROF, SGHT, ZJYL, SONX, and BWAYShould you be buying Modular Medical stock or one of its competitors? The main competitors of Modular Medical include NeuroPace (NPCE), Zynex (ZYXI), Electromed (ELMD), Pulmonx (LUNG), Beauty Health (SKIN), Profound Medical (PROF), Sight Sciences (SGHT), Jin Medical International (ZJYL), Sonendo (SONX), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry. Modular Medical vs. NeuroPace Zynex Electromed Pulmonx Beauty Health Profound Medical Sight Sciences Jin Medical International Sonendo BrainsWay NeuroPace (NASDAQ:NPCE) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, community ranking, media sentiment, earnings, dividends and profitability. Does the MarketBeat Community favor NPCE or MODD? NeuroPace received 25 more outperform votes than Modular Medical when rated by MarketBeat users. However, 100.00% of users gave Modular Medical an outperform vote while only 57.45% of users gave NeuroPace an outperform vote. CompanyUnderperformOutperformNeuroPaceOutperform Votes2757.45% Underperform Votes2042.55% Modular MedicalOutperform Votes2100.00% Underperform VotesNo Votes Do analysts rate NPCE or MODD? NeuroPace presently has a consensus target price of $14.60, suggesting a potential upside of 58.87%. Modular Medical has a consensus target price of $5.00, suggesting a potential upside of 142.72%. Given Modular Medical's stronger consensus rating and higher possible upside, analysts clearly believe Modular Medical is more favorable than NeuroPace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroPace 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Modular Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, NPCE or MODD? NeuroPace has a beta of 1.79, meaning that its stock price is 79% more volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500. Is NPCE or MODD more profitable? Modular Medical has a net margin of 0.00% compared to NeuroPace's net margin of -36.74%. NeuroPace's return on equity of -205.41% beat Modular Medical's return on equity.Company Net Margins Return on Equity Return on Assets NeuroPace-36.74% -205.41% -28.29% Modular Medical N/A -246.01%-191.95% Do insiders and institutionals hold more shares of NPCE or MODD? 78.8% of NeuroPace shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 22.2% of NeuroPace shares are owned by company insiders. Comparatively, 32.3% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media refer more to NPCE or MODD? In the previous week, NeuroPace had 10 more articles in the media than Modular Medical. MarketBeat recorded 11 mentions for NeuroPace and 1 mentions for Modular Medical. Modular Medical's average media sentiment score of 1.75 beat NeuroPace's score of 0.85 indicating that Modular Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroPace 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Modular Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has higher valuation and earnings, NPCE or MODD? Modular Medical has lower revenue, but higher earnings than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroPace$65.42M4.19-$32.96M-$1.00-9.19Modular MedicalN/AN/A-$17.47M-$0.63-3.27 SummaryModular Medical beats NeuroPace on 9 of the 17 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Modular Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MODD vs. The Competition Export to ExcelMetricModular MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$72.60M$4.47B$5.07B$8.90BDividend YieldN/A36.79%4.99%4.07%P/E Ratio-3.2713.2787.8613.46Price / SalesN/A44.831,228.8287.66Price / CashN/A52.2739.5136.27Price / Book10.305.776.946.30Net Income-$17.47M$13.76M$119.12M$225.93M7 Day Performance-3.74%-1.10%-1.84%-1.32%1 Month Performance-7.62%0.56%-3.65%0.60%1 Year Performance100.00%50.90%31.64%26.23% Modular Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MODDModular Medical3.0549 of 5 stars$2.06-1.9%$5.00+142.7%+104.0%$72.60MN/A-3.2739Positive NewsNPCENeuroPace3.7719 of 5 stars$9.19+0.1%$14.60+58.9%+5.6%$274.01M$65.42M0.00170Analyst RevisionZYXIZynex3.7354 of 5 stars$7.86+0.5%$14.00+78.1%-12.6%$249.03M$184.32M52.401,100ELMDElectromedN/A$29.21+4.6%N/A+181.9%$247.06M$57.06M40.57174LUNGPulmonx2.5845 of 5 stars$6.20+3.3%$14.67+136.6%-42.9%$236.93M$68.68M0.00250SKINBeauty Health2.6897 of 5 stars$1.49-7.5%$2.55+71.1%-36.3%$200.29M$398M0.001,030Analyst RevisionPositive NewsPROFProfound Medical2.4531 of 5 stars$7.69-1.8%$13.75+78.8%-31.2%$193.10M$7.20M0.00150Positive NewsSGHTSight Sciences2.5151 of 5 stars$3.73-1.1%$5.50+47.5%+63.6%$191.35M$81.06M0.00210ZJYLJin Medical InternationalN/A$1.01-16.5%N/A-94.1%$187.55M$19.82M0.00245Positive NewsGap DownHigh Trading VolumeSONXSonendoN/A$2.16+1.4%N/A+815.3%$180.60M$44.40M-4.80250Positive NewsGap UpBWAYBrainsWay3.9884 of 5 stars$9.83+1.7%$13.17+33.9%+103.9%$161.28M$31.78M98.31120Gap Up Related Companies and Tools Related Companies NPCE Alternatives ZYXI Alternatives ELMD Alternatives LUNG Alternatives SKIN Alternatives PROF Alternatives SGHT Alternatives ZJYL Alternatives SONX Alternatives BWAY Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MODD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Modular Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Modular Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.